A Study to Evaluate Tislelizumab Combined With Sitravatinib as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection
PHASE2
This is an open label, multi-center, single arm study to evaluate the effic...
Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free.
PHASE3
Open-label, phase III, randomized, stratified (PDL1- vs PDL1+), 3 arms, mul...
Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer
PHASE1
This first-in-human (FIH) study for BNT116 aims to establish the safety pro...